PATENT CLAIM ANALYSIS

Application Number: 15760467
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-02
Patent Classification: ["514", "291000"]

Abstract:
It is an object of the present invention to provide a pharmaceutical composition, which can suppress a reduction in the content of an active ingredient caused by oxidation or decomposition of rapamycin or a derivative thereof, can ensure long-term stability, and has high safety. In the present invention, the inventors have found that (B) a tocopherol derivative and (C) a phospholipid are used in a pharmaceutical formulation comprising rapamycin or a derivative thereof, so that oxidation or decomposition of the rapamycin or a derivative thereof can be suppressed, thereby completing the present invention. The rapamycin or a derivative thereof, and (B) the tocopherol derivative and (C) the phospholipid are preferably in the form of a solid mixture produced by preparing a solution containing these components and then removing the solvent from the solution.

Claim (Index 1):
A pharmaceutical composition comprising (A) rapamycin or a derivative thereof, and (B) a tocopherol derivative and (C) a phospholipid.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 90.0
- Lexical Diversity: 2.06849
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15747604', '11996699', '15305143', '15445670', '13789473']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7318035804234573
- 35 USC 102 Novelty (BERT): 0.5249034355692884
- Combined Prediction Score: 0.7111135659380404
- Mean Citation Score: 193.835812
- Max Citation Score: 328.3211
- Similarity Product: 224.48341827266216

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test